Urmăriți
Cristina Bagacean
Cristina Bagacean
Adresă de e-mail confirmată pe univ-brest.fr
Titlu
Citat de
Citat de
Anul
Vitamin D modulation of innate immune responses to respiratory viral infections
MT Zdrenghea, H Makrinioti, C Bagacean, A Bush, SL Johnston, ...
Reviews in medical virology 27 (1), e1909, 2017
3112017
Accurate classification of germinal center B-cell–like/activated B-cell–like diffuse large B-cell lymphoma using a simple and rapid reverse transcriptase–multiplex ligation …
S Mareschal, P Ruminy, C Bagacean, V Marchand, M Cornic, JP Jais, ...
The Journal of Molecular Diagnostics 17 (3), 273-283, 2015
812015
Cell-specific epigenome-wide DNA methylation profile in long-term cultured minor salivary gland epithelial cells from patients with Sjögren's syndrome
A Charras, OD Konsta, C Le Dantec, C Bagacean, EK Kapsogeorgou, ...
Annals of the Rheumatic Diseases 76 (3), 625-628, 2017
522017
Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies
C Ilcus, C Bagacean, A Tempescul, C Popescu, A Parvu, M Cenariu, ...
OncoTargets and therapy, 2349-2363, 2017
482017
Humoral response to mRNA anti–COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia
C Bagacean, R Letestu, C Al-Nawakil, S Brichler, V Lévy, N Sritharan, ...
Blood advances 6 (1), 207-211, 2022
452022
Complement system: a neglected pathway in immunotherapy
A Bordron, C Bagacean, A Tempescul, C Berthou, E Bettacchioli, S Hillion, ...
Clinical reviews in allergy & immunology 58, 155-171, 2020
372020
Simulated patient and role play methodologies for communication skills and empathy training of undergraduate medical students
C Bagacean, I Cousin, AH Ubertini, M El Yacoubi El Idrissi, A Bordron, ...
BMC medical education 20, 1-8, 2020
302020
Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy
A Bordron, C Bagacean, A Mohr, A Tempescul, B Bendaoud, S Deshayes, ...
Oncotarget 9 (60), 31590, 2018
302018
SERS assessment of the cancer-specific methylation pattern of genomic DNA: Towards the detection of acute myeloid leukemia in patients undergoing hematopoietic stem cell …
V Moisoiu, A Stefancu, SD Iancu, T Moisoiu, L Loga, L Dican, CD Alecsa, ...
Analytical and bioanalytical chemistry 411, 7907-7913, 2019
272019
Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises
C Bagacean, M Zdrenghea, A Tempescul, V Cristea, Y Renaudineau
Immunotherapy 8 (5), 569-581, 2016
222016
Regulatory B lymphocyte functions should be considered in chronic lymphocytic leukemia
A Mohr, Y Renaudineau, C Bagacean, JO Pers, C Jamin, A Bordron
Oncoimmunology 5 (5), e1132977, 2016
192016
Ofatumumab capacity to deplete B cells from chronic lymphocytic leukaemia is affected by C4 complement exhaustion
A Tempescul, C Bagacean, C Riou, B Bendaoud, S Hillion, M Debant, ...
European Journal of Haematology 96 (3), 229-235, 2016
182016
Combining cytogenetic and epigenetic approaches in chronic lymphocytic leukemia improves prognosis prediction for patients with isolated 13q deletion
C Bagacean, C Le Dantec, C Berthou, A Tempescul, H Saad, A Bordron, ...
Clinical Epigenetics 9 (1), 1-11, 2017
172017
STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia
M Debant, M Burgos, P Hemon, P Buscaglia, T Fali, S Melayah, ...
Journal for immunotherapy of cancer 7, 1-13, 2019
162019
17p deletion strongly influences rituximab elimination in chronic lymphocytic leukemia
C Bagacean, A Tempescul, D Ternant, A Banet, N Douet-Guilbert, ...
Journal for ImmunoTherapy of Cancer 7, 1-5, 2019
152019
MicroRNAs associated with a good prognosis of acute myeloid leukemia and their effect on macrophage polarization
A Neaga, C Bagacean, A Tempescul, L Jimbu, O Mesaros, C Blag, ...
Frontiers in immunology 11, 582915, 2021
142021
Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia
C Bagacean, A Tempescul, C Le Dantec, A Bordron, A Mohr, H Saad, ...
Oncotarget 8 (39), 65699, 2017
142017
Hyposialylation must be considered to develop future therapies in autoimmune diseases
A Bordron, M Morel, C Bagacean, M Dueymes, P Pochard, ...
International Journal of Molecular Sciences 22 (7), 3402, 2021
112021
Apoptotic resistance in chronic lymphocytic leukemia and therapeutic perspectives
C Bagacean, C Tomuleasa, A Tempescul, R Grewal, WH Brooks, ...
Critical reviews in clinical laboratory sciences 56 (5), 321-332, 2019
112019
Rapid and complete response to idelalisib in a case of Richter syndrome
C Bagacean, M Zdrenghea, H Saad, C Berthou, Y Renaudineau, ...
OncoTargets and therapy 12, 1181, 2019
92019
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20